Pdevices Inc is categorized under Medical and Laboratory Rubber Sundries and Related Products in Dallas, TX and active since 2004.
Pdevices Inc was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical and Laboratory Rubber Sundries and Related Products business, which does work in the B2B market, and is classified as a Medical and Laboratory Rubber Sundries and Related Products, under code number 326299 by the NAICS.
If you are seeking more information, feel free to contact Dave Oliwa at the company’s single location by writing to 6247 Linden Lane, Dallas, Texas TX 75230 or by phoning (972) 488-1282. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pdevices Inc |
| Contact Person: | Dave Oliwa |
| Address: | 6247 Linden Lane, Dallas, Texas 75230 |
| Phone Number: | (972) 488-1282 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical and Laboratory Rubber Sundries and Related Products |
| SIC Code: | 3069 |
| NAICS Code: | 326299 |
| Share This Business: |
Pdevices Inc was started in 2004 to provide professional Medical and Laboratory Rubber Sundries and Related Products under the SIC code 3069 and NAICS code 326299. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Dave Oliwa for inquiries that concern Pdevices Inc by calling the company number (972) 488-1282, as your correspondence is most welcome. Additionally, the physical location of the single location of Pdevices Inc can be found at the coordinates as well as the street address 6247 Linden Lane in Dallas, Texas 75230.
For its online presence, you may visit Pdevices Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.